# KB Financial Group Inc.: financial statements, quarterly

KB · NYSE · CIK 1445930 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/kb.md) · [Financials](/companies/kb/financials.md) · [Filings](/companies/kb/filings.md) · [Insiders](/companies/kb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/kb/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2008-12-31) | FY2009 (2009-12-31) | FY2010 (2010-12-31) | period not labelled (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [2.6](/filings/0000950123-10-066672.md) | [2.4](/filings/0001193125-11-181096.md) | [3.4](/filings/0001193125-11-181096.md) | [6.9](/filings/0001193125-18-136720.md) | [7.6](/filings/0001193125-19-127722.md) | [5.7](/filings/0001193125-20-118233.md) | [5.6](/filings/0001193125-21-132803.md) | [7.3](/filings/0001193125-22-121490.md) | [20.1](/filings/0001193125-23-116496.md) | [20.6](/filings/0001193125-24-115465.md) | [17.5](/filings/0001193125-25-094961.md) | [16.7](/filings/0001193125-25-094961.md) |
| Total assets | $bn | not reported | [218](/filings/0000950123-10-066672.md) | [223](/filings/0001193125-11-181096.md) | not reported | [409](/filings/0001193125-18-136720.md) | [431](/filings/0001193125-19-127722.md) | [449](/filings/0001193125-20-118233.md) | [562](/filings/0001193125-21-132803.md) | [560](/filings/0001193125-22-121490.md) | [556](/filings/0001193125-23-116496.md) | [554](/filings/0001193125-24-115465.md) | [513](/filings/0001193125-25-094961.md) |
| Total liabilities | $bn | not reported | [203](/filings/0000950123-10-066672.md) | [208](/filings/0001193125-11-181096.md) | not reported | [377](/filings/0001193125-18-136720.md) | [399](/filings/0001193125-19-127722.md) | [415](/filings/0001193125-20-118233.md) | [522](/filings/0001193125-21-132803.md) | [519](/filings/0001193125-22-121490.md) | [517](/filings/0001193125-23-116496.md) | [509](/filings/0001193125-24-115465.md) | [472](/filings/0001193125-25-094961.md) |
| Shareholders' equity | $bn | [13.4](/filings/0000950123-10-066672.md) | [15.1](/filings/0000950123-10-066672.md) | [15.0](/filings/0001193125-11-181096.md) | [29.3](/filings/0001193125-18-136720.md) | [31.9](/filings/0001193125-18-136720.md) | [32.1](/filings/0001193125-19-127722.md) | [33.3](/filings/0001193125-20-118233.md) | [39.1](/filings/0001193125-21-132803.md) | [40.0](/filings/0001193125-22-121490.md) | [38.4](/filings/0001193125-23-116496.md) | [44.1](/filings/0001193125-24-115465.md) | [39.2](/filings/0001193125-25-094961.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, ifrs-full:CashAndCashEquivalents
- Total assets: us-gaap:Assets, ifrs-full:Assets
- Total liabilities: us-gaap:Liabilities, ifrs-full:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity, ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 358,587,722 at 2025-12-31, from the cover of the [20-F filed 2026-04-28](/filings/0001193125-26-183398.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.